PROGRAM CHAIR
Antoinette Moran, MD
Professor, Division Chief of Pediatric Endocrinology and Diabetes
University of Minnesota Medical School
Minneapolis, Minnesota
PROGRAM CO-CHAIRS
Brandon Nathan, MD
Professor, Department of Pediatrics
University of Minnesota Medical School
Minneapolis, Minnesota
Kim Pfotenhauer, DO, FACOFP
Assistant Dean for Clerkship Education
Assistant Professor
Michigan State University College of Osteopathic Medicine
East Lansing, Michigan
PROGRAM DESCRIPTION
This interactive TeleECHO series aims to help clinicians diagnose patients with early-stage type 1 diabetes (T1D) by screening for the presence of islet autoantibodies (IAbs) as well as identify patients with Stage 2 T1D eligible for treatment with the disease-modifying therapy, teplizumab, which is approved to delay progression to Stage 3 T1D. Real-world case examples and discussions are included to highlight various patient-specific characteristics that influence clinical recommendations related to screening and treatment.
TARGET AUDIENCE
Primary care providers (PCPs), Pediatric Endocrinologists, Adult Endocrinologists, Pediatricians, Diabetes Educators, Infusion Professionals, and other allied healthcare professionals who refer, treat, or see patients with or at high risk for T1D.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Identify criteria for T1D screening, focusing on high-risk patients to facilitate timely referral and monitoring
- Interpret T1D screening results and effectively communicate next steps to support patient education and inform treatment decisions
- Identify appropriate patients who would benefit from treatment with disease-modifying therapies for delaying T1D progression based on clinical evidence
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtual activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtual activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
COMMISSION ON DIETETIC REGISTRATION (CDR) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 CPEU.
PHARMACISTS AND PHARMACY TECHNICIANS (ACPE) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 1.0 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Antoinette Moran, MD | Fees for Non-CME/CE Services Received Directly from a Commercial Interest or its Agent: Novo Nordisk DSMB Consulting Fee: Abata Contracted research: Abbott Diabetes, Medtronic, Prevention Bio |
| Brandon Nathan, MD | Has nothing to disclose |
| Kim Pfotenhauer, DO, FACOFP | Consulting Fee: Novo Nordisk |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, General Manager of Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, Sr VP of Operations for Med Learning Group, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Brianna Hefele, PA-C, has nothing to disclose.
- Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Shpetim Karandrea, PhD, MD, Medical Director for Med Learning Group, has nothing to disclose.
- Melissa Johnson, Program Director for Med Learning Group, has nothing to disclose.
- Millena De Brito, Associate Program Manager for Med Learning Group, has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group at [email protected]
RELEASED DATE: September 13, 2025
EXPIRATION DATE: September 13, 2026
Copyright © 2025 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
